{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:56:18Z","timestamp":1791608178702,"version":"4.3.4"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.1001\/jamaophthalmol.2020.4884","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T17:33:39Z","timestamp":1605202419000},"page":"42","source":"Crossref","is-referenced-by-count":14,"title":["Association of Retinal Vascular Occlusion With Women Filling a Prescription for Female Hormone Therapy"],"prefix":"10.1001","volume":"139","author":[{"given":"Delu","family":"Song","sequence":"first","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Nadelmann","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxi","family":"Yu","sequence":"additional","affiliation":[{"name":"Center for Preventive Ophthalmology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"VanderBeek","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"},{"name":"Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"eoi200089r1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaophthalmol.2013.5515","article-title":"Branch retinal vein occlusion: natural history of visual outcome.","volume":"132","author":"Hayreh","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi200089r2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ophtha.2010.01.058","article-title":"Natural history of branch retinal vein occlusion: an evidence-based systematic review.","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi200089r3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0161-6420(81)35080-5","article-title":"Retinal arterial obstruction in children and young adults.","volume":"88","author":"Brown","year":"1981","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi200089r4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0161-6420(82)34853-8","article-title":"Central retinal artery obstruction and visual acuity.","volume":"89","author":"Brown","year":"1982","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi200089r5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease.","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"11","key":"eoi200089r6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses\u2019 health study.","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"eoi200089r7","first-page":"40","article-title":"Cardiovascular effects of oral contraceptives: a review.","volume":"34","author":"Stubblefield","year":"1989","journal-title":"Int J Fertil"},{"issue":"3","key":"eoi200089r8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0010-7824(98)00019-5","article-title":"Hormonal contraception and risk of cardiovascular disease: an international perspective.","volume":"57","author":"Farley","year":"1998","journal-title":"Contraception"},{"issue":"1","key":"eoi200089r9","first-page":"91","article-title":"Venous thromboembolism in relation to oral contraceptive use.","volume":"69","author":"Helmrich","year":"1987","journal-title":"Obstet Gynecol"},{"issue":"18","key":"eoi200089r10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"issue":"3","key":"eoi200089r11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study.","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"eoi200089r12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism.","volume":"278","author":"Jordan","year":"1961","journal-title":"The Lancet"},{"issue":"12","key":"eoi200089r13","doi-asserted-by":"publisher","first-page":"1984.e1","DOI":"10.1016\/j.ajem.2017.07.084","article-title":"Pulmonary embolism due to exogenous estrogen intoxication.","volume":"35","author":"\u00c7elik","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"1","key":"eoi200089r14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives.","volume":"335","author":"Petitti","year":"1996","journal-title":"N Engl J Med"},{"issue":"9026","key":"eoi200089r15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study.","volume":"348","author":"Anon.","year":"1996","journal-title":"Lancet"},{"issue":"9026","key":"eoi200089r16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(95)12394-6","article-title":"Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study.","volume":"348","author":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1996","journal-title":"Lancet"},{"issue":"954","key":"eoi200089r17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/pgmj.2004.026369","article-title":"Retinal vein thrombosis associated with a herbal phytoestrogen preparation in a susceptible patient.","volume":"81","author":"Lai Cheong","year":"2005","journal-title":"Postgrad Med J"},{"issue":"Pt 6","key":"eoi200089r18","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/eye.1999.236","article-title":"Hormone replacement therapy and retinal vein occlusion.","volume":"13","author":"Cahill","year":"1999","journal-title":"Eye (Lond)"},{"issue":"5","key":"eoi200089r19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/bjo.84.5.546e","article-title":"Combined central retinal vein occlusion and cilioretinal artery occlusion in a patient on hormone replacement therapy.","volume":"84","author":"Murray","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"eoi200089r20","first-page":"1084","article-title":"Oral contraceptive-induced central retinal artery occlusion.","volume":"50","author":"Rekhi","year":"2002","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"eoi200089r21","first-page":"473","article-title":"Retinal central artery occlusion in a young woman after ten days of a drospirenone-containing oral contraceptive (Yasmin).","volume":"98","author":"Girolami","year":"2007","journal-title":"Thromb Haemost"},{"issue":"8","key":"eoi200089r22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1055\/s-0031-1273197","article-title":"[Hemicentral retinal artery occlusion due to oral contraceptives].","volume":"228","author":"Schmidt","year":"2011","journal-title":"Klin Monbl Augenheilkd"},{"issue":"5","key":"eoi200089r23","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1136\/bjo.82.5.538","article-title":"Oral contraception and eye disease: findings in two large cohort studies.","volume":"82","author":"Vessey","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"7023","key":"eoi200089r24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study.","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"issue":"1","key":"eoi200089r25","first-page":"15","article-title":"Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization.","volume":"14","author":"Young","year":"2008","journal-title":"Am J Manag Care"},{"issue":"4","key":"eoi200089r26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/acr.22483","article-title":"Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study.","volume":"67","author":"Desai","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"eoi200089r27","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1097\/IAE.0000000000001869","article-title":"Testosterone supplementation and retinal vascular disease.","volume":"38","author":"Dedania","year":"2018","journal-title":"Retina"},{"issue":"6444","key":"eoi200089r28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/bmj.289.6444.530-a","article-title":"Oral contraceptives and stroke: findings in a large prospective study.","volume":"289","author":"Vessey","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1 Pt 1","key":"eoi200089r29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0002-9378(99)70182-1","article-title":"Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.","volume":"180","author":"Schwingl","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"eoi200089r30","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1210\/jc.2015-4063","article-title":"Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density.","volume":"101","author":"Cartwright","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2772809\/jamaophthalmology_song_2020_oi_200089_1610718699.09668.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T16:05:38Z","timestamp":1611158738000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2772809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.4884","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}